Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for MOGAMULIZUMAB
- Study of Mogamulizumab With DA-EPOCH in Patients With Aggressive T Cell Lymphoma
- Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas
- Mogamulizumab and Brentuximab Vedotin in CTCL and Mycosis Fungoides
- Third-Party Natural Killer Cells and Mogamulizumab for the Treatment of Relapsed or Refractory Cutaneous T-cell Lymphomas or Adult T-Cell Leukemia/Lymphoma
- Mogamulizumab Q4week Dosing in Participants With R/R CTCL
- Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome
- Phase I Study of Recombinant Human IL-15 (rhIL-15) and Mogamulizumab for People With Refractory or Relapsed Adult T-Cell Leukemia and Mycosis Fungoides/Sezary Syndrome
- Anti-CCR4 Monoclonal Antibody (Mogamulizumab) and Total Skin Electron Beam Therapy (TSEB) in Patients With Stage IB-IIB Cutaneous T-Cell Lymphoma
- KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors
- A Study of PF-05082566 In Combination With Mogamulizumab In Patients With Advanced Solid Tumors
- Study of Mogamulizumab + Docetaxel in Subjects With Non-small Cell Lung Cancer
- Study of KW-0761 Versus Vorinostat in Relapsed/Refractory CTCL
- KW-0761 or Investigator's Choice in Subjects With Previously Treated Adult T-cell Leukemia-Lymphoma (ATL)
Clinical trials list
click for details